Language: English
Published by Singapore, Springer Singapore : Imprint: Springer., 2021
ISBN 10: 9811618720 ISBN 13: 9789811618727
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
First Edition
1st ed. 2021. XV, 229 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Seller: Open Books, Chicago, IL, U.S.A.
hardcover. Condition: New. Open Books is a nonprofit social venture that provides literacy experiences for thousands of readers each year through inspiring programs and creative capitalization of books.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New.
Condition: New. 1st ed. 2021 edition NO-PA16APR2015-KAP.
Taschenbuch. Condition: Neu. Breast Cancer Research and Treatment | Innovative Concepts | Ouissam Al Jarroudi (u. a.) | Taschenbuch | Cancer Treatment and Research | viii | Englisch | 2025 | Springer | EAN 9783031336041 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Springer International Publishing, Springer International Publishing, 2025
ISBN 10: 3031336046 ISBN 13: 9783031336041
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 244 pages. 9.25x6.10x0.67 inches. In Stock.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 137.84
Quantity: Over 20 available
Add to basketCondition: New. In.
Taschenbuch. Condition: Neu. Ovarian Cancer Biomarkers | Mapping to Improve Outcomes | Khalid El Bairi | Taschenbuch | xv | Englisch | 2022 | Springer | EAN 9789811618758 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 148.08
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 148.08
Quantity: Over 20 available
Add to basketCondition: New. In.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st ed. 2023 edition NO-PA16APR2015-KAP.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Language: English
Published by Springer International Publishing, 2024
ISBN 10: 3031336011 ISBN 13: 9783031336010
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters.Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management.The closing chapters deal with the challenges of conducting research in the era of precision medicine forcancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st ed. 2020 edition NO-PA16APR2015-KAP.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. XV, 185 26 illus., 25 illus. in color. 1st ed. 2020 edition NO-PA16APR2015-KAP.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing | A Big Chapter in the Tale | Khalid El Bairi | Taschenbuch | xv | Englisch | 2021 | Springer | EAN 9783030538231 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Springer Nature Singapore, Springer Nature Singapore, 2021
ISBN 10: 9811618720 ISBN 13: 9789811618727
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.
Language: English
Published by Springer International Publishing, 2021
ISBN 10: 3030538230 ISBN 13: 9783030538231
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book reviews the potential of next-generation sequencing (NGS) in research on and management of colorectal cancer (CRC), a leading cause of death worldwide and one of the most biologically and clinically heterogeneous cancers. It critically discusses findings from recent large-scale studies, clinical trials and meta-analyses and offers an introduction to the management of CRC in the era of precision medicine. In CRC, dozens of driver and passenger mutations are associated with the malignant transformation of epithelial cells. Consequently, the book discusses recent advances in our understanding of the genetics of CRC as a biomarker, the advent of NGS technologies in modern genomics, and the impact of NGS technology on the management of CRC. Furthermore, it highlights the potential of NGS in the context of liquid biopsy and single-cell sequencing in CRC, as well as its role in shedding light on the link between gut microbiota, immune-checkpoint blockade and CRC. The book concludes with a chapter on the limitations and cost-effectiveness of NGS in CRC. Given its scope, the book will appeal to all those interested in learning about the potential of NGS in advancing CRC research and patient care.
Language: English
Published by Springer International Publishing, 2020
ISBN 10: 3030538206 ISBN 13: 9783030538200
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book reviews the potential of next-generation sequencing (NGS) in research on and management of colorectal cancer (CRC), a leading cause of death worldwide and one of the most biologically and clinically heterogeneous cancers. It critically discusses findings from recent large-scale studies, clinical trials and meta-analyses and offers an introduction to the management of CRC in the era of precision medicine. In CRC, dozens of driver and passenger mutations are associated with the malignant transformation of epithelial cells. Consequently, the book discusses recent advances in our understanding of the genetics of CRC as a biomarker, the advent of NGS technologies in modern genomics, and the impact of NGS technology on the management of CRC. Furthermore, it highlights the potential of NGS in the context of liquid biopsy and single-cell sequencing in CRC, as well as its role in shedding light on the link between gut microbiota, immune-checkpoint blockade and CRC. The book concludes with a chapter on the limitations and cost-effectiveness of NGS in CRC. Given its scope, the book will appeal to all those interested in learning about the potential of NGS in advancing CRC research and patient care.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 244 pages. 9.25x6.10x9.21 inches. In Stock.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 200 pages. 9.25x6.10x9.21 inches. In Stock.
Condition: New.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.